期刊文献+

TRAIL联合顺铂诱导非小细胞肺癌细胞凋亡的作用 被引量:2

暂未订购
导出
摘要 肿瘤坏死因子相关凋亡诱导配体(TRAIL)是体内天然的抗肿瘤药物,可由人体的免疫系统正常表达,目前在美国TRAIL已进入临床Ⅱ期研究阶段。本课题组在以往研究中发现,TRAIL在胶质母细胞瘤诱导凋亡过程中,发生凋亡抵抗而不能引起肿瘤细胞凋亡。因此,本文将研究TRAIL和化疗药物顺铂对非小细胞肺癌细胞联合诱导凋亡的作用,为TRAIL作为新药开发提供更进一步的理论依据,此方面研究国内还未见相关报道。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2012年第24期5555-5556,共2页 Chinese Journal of Gerontology
基金 国家自然科学基金青年基金(No.81201671) 吉林省自然科学基金(No.202015242) 吉林省教育厅项目(No.2012330 2012491)
  • 相关文献

参考文献9

  • 1Anita C,Ling Qi,Mulligan P. TRAIL agonists on clinical trials for cancer therapy:the promises and the challenges[J].Rev Recent Clin Trials (Online),2009,(04):34-41.
  • 2Li YC,Tzeng CC,Song JH. Genomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy[J].Clinical Cancer Research,2006,(09):2716-2729.doi:10.1158/1078-0432.CCR-05-1980.
  • 3齐玲,于洪泉,金宏,丁丽娟,温娜,唐泽波,李蕴潜.caspase-8在胶质母细胞瘤抵抗TRAIL诱导凋亡中的作用[J].吉林大学学报(医学版),2011,37(4):612-616. 被引量:10
  • 4Walczak H,Miller RE,Ariail K. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo[J].Nature Medicine,1999,(02):157-163.doi:10.1038/5517.
  • 5Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily[J].Nature Reviews Cancer,2002,(06):420-430.
  • 6南栗岩,齐玲,肖振晶,赵庆旭,王伟,于洪泉.原代培养的恶性胶质瘤细胞表达死亡受体与TRAIL抵抗的关系[J].中国老年学杂志,2011,31(18):3591-3592. 被引量:6
  • 7Bellail AC,Tse MC,Song JH. DRS-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas[J].Journal of Cellular and Molecular Medicine,2010,(6A):1303-1317.
  • 8Song JH,Tse MC,Bellail A. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells[J].Cancer Research,2007,(14):6946.
  • 9Gajewski TF. On the TRAIL toward death receptor based cancer therapeutics[J].Journal of Clinical Oncology,2007.1305.

二级参考文献21

  • 1Bellail AC, Qi L, Mulligan P, et al. TRAIL agonists on clinical trials for cancer therapy:the promises and the challenges [J]. Rev Recent Clin Trials ,2009 ;4( 1 ) :34-41.
  • 2Sathomsumetee S, Reardon DA, Desjardins A, et al. Molecularly targeted therapy for malignant glioma[J]. Cancer,2007 ; 110( 1 ) : 13-24.
  • 3Bellail A, Tse MC, Song JH, et al. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas[J].J Cell Mol Med ,2010 ; 14 (6A) : 1303-17.
  • 4Xiao C, Yang BF, Asadi N, et al. Tumor necrosis factor-related apoptosis- inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells [J]. J Biol Chem, 2002 ; 277 ( 28 ) : 25020 -5.
  • 5Song JH, Bellail A, Tse MC, et al. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis[J]. J Neurosci ,2006 ;26 (12) :3299-308.
  • 6Griffith TS, Anderson RD, Davidson BL, et al. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis[J]. J Immunol,2000 ; 165 ( 5 ) :2886-94.
  • 7Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy[J].Cytokine Growth Factor Rev,2003 ; 14(3-4) :337-48.
  • 8Anita C. Qi L, Mulligan P, et al. TRAll. agonisls on clinical trials for cancer therapy: The promises and the challenges [J], Rev Recent Clin Trials (Online), 2009, 4 (1): 34-41.
  • 9Hopkins-Donaldson S, Bodmer JL, Bourloud KB, el ai. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induccd apoptosis[J]. Cancer Res, 2000, 60 (16): 4313-4319.
  • 10Li YC, Tzeng CC, Song JH, et al. Genomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor related apoptosis-inducing ligand and chemotherapy [J]. Clin Cancer Rcs, 2006, 12 (9): 2716-2729.

共引文献11

同被引文献8

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部